RecruitingNCT06933836

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma

Sponsor

Barnet Dulaney Perkins Eye Centers

Enrollment

55 participants

Start Date

Mar 31, 2025

Study Type

OBSERVATIONAL

Conditions

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Min Age: 30 Years

Primary open angle glaucoma
Patients age 30 or greater with an IOP of 18-26 mmHg
Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
DSLT procedure

History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
Angle closure patients
Ocular Hypertension
Baseline VF MD of worse than -12dB
Uncontrolled systemic microvascular disease (eg. HTN, DM)
Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

DEVICEDSLT enables newly diagnosed patients to remain well controlled and off medications

DSLT enables newly diagnosed patients to remain well controlled and off medications

Barnet Dulaney Perkins Eye Centers

Mesa, Arizona, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT06933836